The high frequency of mutations in SMAD4 is consistent with the findings of many previous studies in which SMAD4 was analyzed as a transcription factor playing a role in the activation of many cancer-related genes in response to TGFB/BMP signaling (123–126). The gene discussed is SMAD4; the disease is cancer.